Androisoxazole
Androisoxazole, also known as 17α-methyl-5α-androstanoisoxazol-17β-ol, is an orally active anabolic-androgenic steroid and a 17α-alkylated derivative of dihydrotestosterone that is marketed in Spain and Italy. It is closely related to stanozolol, differing only in having an isoxazole instead of pyrazole ring fused to the A ring, and is also related to furazabol, prostanozol, and danazol.